Drug intelligence / Profile preview

Ho Chai Kung Tji Thung San

Development stage: Unknown
Lead developer: Jacobson Pharma
Modality: Small Molecules
Administration: Oral

Overview

Ho Chai Kung Tji Thung San is an over-the-counter analgesic and antipyretic powder formulation from Hong Kong, marketed for rapid relief of headache (including migraine), toothache, fever, influenza and pain associated with colds. It is a combination product whose principal Western active ingredients are paracetamol (acetaminophen), which reduces pain and fever mainly through central inhibition of prostaglandin synthesis, and caffeine, which provides mild central nervous system stimulation and can enhance analgesic efficacy. The product is typically supplied as single-dose sachets of powder to be dissolved in hot or boiled water and taken orally several times daily as needed.

Brand names: Ho Chai Kung Tji Thung San
Other names: Ho Chai Kung Zhi Tong Tui Re San

Beyond the preview

Go deeper on Ho Chai Kung Tji Thung San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ho Chai Kung Tji Thung San.

Explore the full profile